Notably, no significant increases in markers of inflammation or oxidative stress were observed in the liver of Gclc L-KO mice compared to Gclc WT mice (Fig
showed that fasting glucose levels were completely normalized by GLP-1 infusion in T2DM patients [20]
Which is more suitable for a patient with neuroinflammatory conditions, including anxiety, depression, and Attention Deficit Hyperactivity Disorder (ADHD), semaglutide (GLP-1 receptor agonist) or tirzepatide, considering their potential anti-inflammatory effects and safety profiles?
Even if the answer is were still figuring that out. At least your experience will be documented
When water intake drops while the medication simultaneously slows digestion and allows more water absorption from stool, constipation becomes almost inevitable without conscious effort to stay hydrated
You know they want to make less food decisions in general